Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
β1-Integrin– and KV1.3 channel–dependent signaling stimulates glutamate release from Th17 cells
Katharina Birkner, … , Frauke Zipp, Stefan Bittner
Katharina Birkner, … , Frauke Zipp, Stefan Bittner
Published October 29, 2019
Citation Information: J Clin Invest. 2020;130(2):715-732. https://doi.org/10.1172/JCI126381.
View: Text | PDF
Research Article Autoimmunity Neuroscience

β1-Integrin– and KV1.3 channel–dependent signaling stimulates glutamate release from Th17 cells

  • Text
  • PDF
Abstract

Although the impact of Th17 cells on autoimmunity is undisputable, their pathogenic effector mechanism is still enigmatic. We discovered soluble N-ethylmaleimide–sensitive factor attachment receptor (SNARE) complex proteins in Th17 cells that enable a vesicular glutamate release pathway that induces local intracytoplasmic calcium release and subsequent damage in neurons. This pathway is glutamine dependent and triggered by binding of β1-integrin to vascular cell adhesion molecule 1 (VCAM-1) on neurons in the inflammatory context. Glutamate secretion could be blocked by inhibiting either glutaminase or KV1.3 channels, which are known to be linked to integrin expression and highly expressed on stimulated T cells. Although KV1.3 is not expressed in CNS tissue, intrathecal administration of a KV1.3 channel blocker or a glutaminase inhibitor ameliorated disability in experimental neuroinflammation. In humans, T cells from patients with multiple sclerosis secreted higher levels of glutamate, and cerebrospinal fluid glutamine levels were increased. Altogether, our findings demonstrate that β1-integrin– and KV1.3 channel–dependent signaling stimulates glutamate release from Th17 cells upon direct cell-cell contact between Th17 cells and neurons.

Authors

Katharina Birkner, Beatrice Wasser, Tobias Ruck, Carine Thalman, Dirk Luchtman, Katrin Pape, Samantha Schmaul, Lynn Bitar, Eva-Maria Krämer-Albers, Albrecht Stroh, Sven G. Meuth, Frauke Zipp, Stefan Bittner

×

Figure 2

Th17 cells possess a vesicular glutamate release pathway.

Options: View larger image (or click on image) Download as PowerPoint
Th17 cells possess a vesicular glutamate release pathway.
(A) Polarized ...
(A) Polarized murine Th17 cells from MOG35–5-specific 2D2 mice were cultured in glutamate- and glutamine-free media or glutamine-supplemented (l-Gln) media for 4 and 24 hours, followed by measurement of glutamate levels (n = 6–7). (B) Glutamate levels were measured after pharmacological blocking of the enzyme glutaminase by 10 μM BPTES and external supply of 4 mM l-glutamine after 4 and 24 hours (n = 6–8). (C) Got2 mRNA analysis was performed with Th17 cells compared with unstimulated Th17 cells after CD3 and CD28 stimulation (n = 7–15). (D) Th17 (n = 12) and Th1 (n = 5) cells were cultured for 5 days, and the levels of granzyme B and perforin were compared using flow cytometry. (E) Glutamate secretion by naive and Th1- and Th17-differentiated cells (same donors, n = 7) that were cultured in glutamate- and glutamine-free media for 24 hours. Data indicate the mean ± SEM. *P < 0.05, by Mann-Whitney U test (C and D) or 1-way ANOVA with Tukey’s (E) or Dunnett’s (A and B) post hoc test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts